Valsartan combination therapy in the management of hypertension – patient perspectives and clinical utility
David T Nash1, Michael S McNamara21Syracuse Preventive Cardiology, Syracuse, New York, USA; 2Oxford PharmaGenesis Inc., Newtown, Pennsylvania, USAAbstract: The morbidity and mortality benefits of lowering blood pressure (BP) in hypertensive patients are well established, with most individuals requir...
Saved in:
Main Authors: | David T Nash (Author), Michael S McNamara (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2009-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan
by: Varagic J, et al.
Published: (2014) -
Clinical utility of fixed-combination telmisartan–amlodipine in the treatment of hypertension
by: Segura J, et al.
Published: (2011) -
Spotlight on valsartan–sacubitril fixed-dose combination for heart failure: the evidence to date
by: Vilela-Martin JF
Published: (2016) -
ANTIHYPERTENSIVE EFFICACY AND INFLUENCE ON SEXUAL FUNCTION OF VALSARTAN AND VALSARTAN AND HYDROCHLOROTHIAZIDE COMBINATION IN SMOKERS VERSUS NON-SMOKERS WITH ARTERIAL HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2015) -
ANTIHYPERTENSIVE EFFICACY AND INFLUENCE ON SEXUAL FUNCTION OF VALSARTAN AND VALSARTAN AND HYDROCHLOROTHIAZIDE COMBINATION IN SMOKERS VERSUS NON-SMOKERS WITH ARTERIAL HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2015)